中国CGM多个共识发布

Core Insights - The recent academic conference on endocrine metabolic diseases highlighted the importance of integrated continuous glucose monitoring (iCGM) technology for diabetes management, emphasizing its role in improving patient outcomes and reducing complications [1][2] Group 1: iCGM Technology and Standards - The iCGM technology represents international high standards for blood glucose monitoring, allowing integration with other medical devices for insulin dosage adjustments [1] - The iCGM standard includes strict requirements across 11 performance indicators, establishing it as the gold standard for glucose monitoring [1] - The National Medical Products Administration of China has introduced iCGM classification and standards, raising accuracy and stability requirements for CGM in the country [1] Group 2: Diabetes Complications and Management - Diabetes complications can lead to severe health issues, including a 1.5-2.5 times increased risk of coronary heart disease and stroke [1] - Early and strict blood sugar control can create a "metabolic memory" effect, significantly lowering the risk of complications such as diabetic kidney disease and retinopathy [1] - A comprehensive blood sugar management approach is necessary, integrating both hospital treatment and outpatient care [2] Group 3: Real-World Research Findings - The REFLECT real-world study indicates that using continuous glucose monitoring systems can significantly reduce hospitalization risks for cardiovascular complications in diabetes patients [2] - For type 1 diabetes patients with a history of severe hypoglycemia, hospitalization rates related to cardiovascular diseases decreased by 78% [2] - Adult type 2 diabetes patients also experienced a reduction in hospitalization rates for cardiovascular complications [2]